Dual-isotope lymphoscintigraphy using albumin nanocolloid differentially labeled with ¹¹¹In and ^99mTc

References

• Chagpar AB, McMasters KM. Sentinel lymph node biopsy for breast cancer: From investigational procedure to standard practice. Expert Rev Anticancer Ther 2004; 4: 903–12
   PubMedGoogle Scholar
• Eedy DJ. Introducing controversies in dermatology: Sentinel lymph node biopsy for cutaneous melanoma-a useful technique or a waste of time?. Br J Dermatol 2004; 151: 267–8
   PubMedGoogle Scholar
• Werner JA, Dunne AA, Ramaswamy A. The sentinel node concept in head and neck cancer: Solution for the controversies in the N0 neck?. Head Neck 2004; 26: 603–11
   PubMed Web of Science ®Google Scholar
• Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000; 76: 40–4
   PubMedGoogle Scholar
• Faries MB, Bleicher RJ, Ye X, Essner R, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg 2004; 139: 870–6
   PubMedGoogle Scholar
• Braat AE, Oosterhuis JW, Moll FC. Successful sentinel node identification in colon carcinoma using Patent Blue V. Eur J Surg Oncol 2004; 30: 633–7
   PubMed Web of Science ®Google Scholar
• Wagner JD, Schauwecker D, Davidson D, Coleman JJ, Saxman S, Hutchins G, et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 1999; 17: 1508–15
   PubMedGoogle Scholar
• Reintgen DS, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759–67
   PubMed Web of Science ®Google Scholar
• Statius Muller MG, Borgstein PJ, Pijpers R, van Leeuwen PA, van Diest PJ, Gupta A, et al. Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up. Ann Surg Oncol 2000; 7: 461–8
   PubMed Web of Science ®Google Scholar
• Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001; 192: 399–409
   PubMedGoogle Scholar
• Noguchi M. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat 2004; 84: 261–71
   PubMedGoogle Scholar
• Celliers L, Mann GB. Alternative sites of injection for sentinel lymph node biopsy in breast cancer. ANZ J Surg 2003; 73: 600–4
   PubMedGoogle Scholar
• Chagpar A, Martin RC, Chao C, Wong SL, Edwards MJ, Tuttle T, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004; 139: 614–8
   PubMedGoogle Scholar
• Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, et al. Quantification of lymphatic function for investigation of lymphoedema: Depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med 2002; 43: 318–24
   PubMed Web of Science ®Google Scholar
• Pain SJ, Barber RW, Ballinger JR, Solanki CK, O'Mahony S, Mortimer PS, et al. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging 2003; 30: 657–61
   PubMedGoogle Scholar
• Pain SJ, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Purushotham AD, et al. Transport of radiolabeled immunoglobulin injected into the web spaces of the hands of normal subjects and patients with breast cancer-related lymphedema. J Vasc Res 2004; 41: 183–92
   PubMedGoogle Scholar
• Pain SJ, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Purushotham AD, et al. Local vascular access of radioprotein injected subcutaneously in normal subjects and patients with breast cancer-related lymphedema. J Nucl Med 2004; 45: 789–96
   PubMedGoogle Scholar
• Mitterhauser M, Wadsak W, Mien LK, Eidherr H, Roka S, Zettinig G, et al. The labeling of Nanocoll® with [111In] for dual-isotope scanning. Appl Radiat Isot 2003; 59: 337–42
   PubMedGoogle Scholar
• Ergun EL, Ercan MT, Asansu A, Unsal IS. Evaluation of 99mTc-HIG as a lymphoscintigraphic agent in rabbits. Nucl Med Commun 1998; 19: 665–70
   PubMedGoogle Scholar
• Svensson W, Glass DN, Bradley D, Peters AM. Measurement of lymphatic function with Tc-99m labeled polyclonal immunoglobulin. Eur J Nucl Med 1999; 26: 504–10
   PubMedGoogle Scholar
• Hollander W, Reilly P, Burrows BA. Lymphatic flow in human subjects as indicated by the disappearance of 131I labeled albumin from the subcutaneous tissue. J Clin Invest 1961; 40: 222–3
   PubMed Web of Science ®Google Scholar
• Fowler JC, Solanki CK, Barber RW, Swift EA, Guenther I, Ballinger JR, et al. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer. Nucl Med Commun 2004; 25: 935–40
   PubMed Web of Science ®Google Scholar